Maquet CV: Old Name, New Emerging Mid-Cap Strategic Acquirer
Executive Summary
After some recent changes – like moving its headquarters to the US and spending $2.3 billion on several recent deals – Maquet is becoming just what the cardiovascular device industry needs: a mid-sized company committed to an aggressive acquisition strategy.